Key facts
- It has raised $2.1M across 2 recorded rounds; the latest was Seed Round ($1.0M) in Jan 2024.
- Notable investors include Creative Destruction Lab, MedTech Innovator, Launch Tennessee, InvestTN, Vanderbilt University — 9 tracked in total.
- Augment Health has filed 14 Form Ds with the SEC since 2022, most recently Nov 2025 ($1.0M sold to 10 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Augment Health
Funding rounds
2 roundsAbout Augment Health
Developer of neurogenic bladder management medical devices designed to improve patients' lives. The company's devices can be attached to the catheter to monitor the urine level and notify the users or care providers when the catheter is full, enabling patients to control and promote bladder health by preventing bladder muscle atrophy.
- Sector
- Healthcare
- HQ
- Nashville, TN, United States
- Founded
- 2021
- Employees
- 3
- Website
- augment.health/
- Ownership
- Privately Held (backing)
Augment Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Augment Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Augment Health in its N-PORT filings yet. We sweep new filings monthly.